ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor
Year: 2022
Type: article
Source: American Heart Journal
Institutions: Harvard University, Massachusetts General Hospital, Kaiser Permanente, University of California, San Francisco, Kaiser Permanente Bernard J. Tyson School of Medicine, Kaiser Permanente Northern California, Duke University, Duke Clinical Research Institute, University of Massachusetts Chan Medical School, Pfizer (United States), Bristol-Myers Squibb (United States), iRhythm (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: American Heart Association, Bristol-Myers Squibb, International Business Machines Corporation, Pfizer, Bayer, Merck, Sanofi, Medtronic, Heart Rhythm Society, Boehringer Ingelheim, National Institutes of Health, Johnson and Johnson, National Institute on Aging, National Heart, Lung, and Blood Institute
Awards: FHS-NEXT - Framingham Novel EXam using Technology, Automated detection and prediction of atrial fibrillation during sepsis, Precision Medicine in Ischemic Stroke and Atrial Fibrillation (PreMISe-AF), Anticoagulant Use, Safety, and Effectiveness for Ischemic Stroke Prevention in Nursing Home Residents with Atrial Fibrillation, Detecting bleeding events using EHRs for prediction in Afib, Smartwatch Monitoring for Atrial Fibrillation After Stroke, RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study, The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases, Genomics of Cardiac Arrhythmias
OpenAlex ID: W4224320256